Pharmaceuticals & Life Sciences Articles & Blogs

Oxford University Study Finds Genetics Play Role in Durability and Efficacy of COVID Vaccines

Wednesday, 19 October 2022

Further to the University of Oxford's pivotal role in rapidly developing a vaccine for COVID-19, the University is again at the centre of a COVID discovery - this time finding out why some people have better immunity after a COVID-19 vaccine than others.

Oxford University Study Finds Genetics Play Role in Durability and Efficacy of COVID Vaccines

Articles & Blogs Pharma & Life Sciences

Genomics Plc and Our Future Health Collaboration Heralds Exciting Era for Early Disease Diagnosis

Wednesday, 19 October 2022

The holy grail for better health outcomes is early diagnosis. The combination of genomics and health data are key to achieving that. Two leading initiatives from the UK have now announced an exciting collaboration.

Genomics Plc and Our Future Health Collaboration Heralds Exciting Era for Early Disease Diagnosis

Articles & Blogs Pharma & Life Sciences

EMA Offers Pilot Scheme to Nurture Development of ATMPs

Wednesday, 26 October 2022

The European Medicines Agency has launched a pilot to help EEA based non-profit entities navigate the regulatory requirements to bring Advanced Therapy Medicinal Products (ATMPs) to market.

EMA Offers Pilot Scheme to Nurture Development of ATMPs

Articles & Blogs Pharma & Life Sciences

Alzheimer's Treatment - At Last Some Promising Hope?

Wednesday, 19 October 2022

After years of lack of progress, hope may now be coming for the treatment of Alzheimer's Disease (AD).

Alzheimer's Treatment - At Last Some Promising Hope?

Articles & Blogs Pharma & Life Sciences

DHSC Consults on Population Bias in Medical Devices - Have Your Say

Wednesday, 14 September 2022

The Department for Health and Social Care (DHSC) is consulting on population bias within medical devices, to find out what biases there may be against people with different ethnicity or other social or demographic characteristics.

DHSC Consults on Population Bias in Medical Devices - Have Your Say

Articles & Blogs Pharma & Life Sciences

DHSC Releases Policy Guidelines for Access to NHS Health and Social Care Data

Wednesday, 14 September 2022

Access to health data is important to facilitate advancements in prevention, detection and early treatment of diseases. By finding links between health, lifestyle and genomic data, patients can be screened for risk factors and have measures put in place.

DHSC Releases Policy Guidelines for Access to NHS Health and Social Care Data

Articles & Blogs Pharma & Life Sciences

ABPI President Asks New UK Prime Minister to Do More to Support Pharma

Wednesday, 14 September 2022

The UK Government must do more to support pharma to see Boris Johnson's promise to make Britain a science superpower by 2030, come to fruition. That's the call to action from Pinder Sahota, President of the Association of British Pharmaceutical Industry.

ABPI President Asks New UK Prime Minister To Do More To Support Pharma

Pharma & Life Sciences

Stevenage Life Sciences Boost with New Lab Facility with 5,000 Jobs

Tuesday, 09 August 2022

Stevenage in Hertfordshire is already a leading life sciences hub, with leading institutions to help exciting early stage businesses at the Stevenage Bioscience Catalyst and Cell and Gene Therapy Catapult, on the GSK site.

Stevenage Life Sciences Boost with New Lab Facility with 5,000 Jobs

Articles & Blogs Pharma & Life Sciences

MHRA Joins New Partnerships to Set International Regulatory Standards

Tuesday, 09 August 2022

The Medicines and Healthcare products Regulatory Agency (MHRA), the UK's life sciences regulator, is joining three international partnerships designed to agree and set common regulatory standards.

MHRA Joins New Partnerships to Set International Regulatory Standards

High Court Applies Business Common Sense to Allow Solicitor to Charge Client

Tuesday, 09 August 2022

Despite best intentions, parties do not always make everything clear in their commercial contracts. The High Court had to decide on the interpretation recently when a contract was not clear.

High Court Applies Business Common Sense to Allow Solicitor to Charge Client

Articles & Blogs Pharma & Life Sciences

Recent Data Protection Developments - What Do Life Sciences Organisations Need to Know?

Wednesday, 08 June 2022

Data protection law has been in a state of flux for a number of years now, with the relentless pace of technological development, new ways of working, and external factors such as Brexit, all informing changes in the law and regulatory guidance.

Key Recent Developments in Data Protection - What Do Life Sciences Organisations Need to Know?

Articles & Blogs Pharma & Life Sciences

New UK Medicine Batch Testing Regime - Have Your Say

Wednesday, 08 June 2022

The Department for Health and Social Care is consulting on a new regime for batch testing of medicines which have been imported.

New UK Medicine Batch Testing Regime - Have Your Say

Articles & Blogs Pharma & Life Sciences

Supply and Distribution Agreements - New Competition Law Regime in Force

Wednesday, 08 June 2022

Parties to agreements sometimes include restrictions, such as exclusive territory, minimum purchase requirements, recommended pricing, or some other requirements which may cause a problem under competition law.

Supply and Distribution Agreements - New Competition Law Regime in Force

Articles & Blogs Pharma & Life Sciences

Blockchain - A Solution to the Pain Points in Genomics?

Friday, 20 May 2022

For those working in the Pharmaceuticals and Life Sciences sector, genomics is a familiar subject.

Blockchain - A Solution to the Pain Points in Genomics?

Articles & Blogs Pharma & Life Sciences

What Does 'Contractual Exclusion of Loss of Profits' Mean? Court of Appeal Decides

Tuesday, 10 May 2022

Parties to commercial contracts often look to exclude and limit liability. Those clauses can take many forms. Parties often exclude liability for loss of profits, loss of revenue or loss of savings. But what does this mean?

What Does 'Contractual Exclusion of Loss of Profits' Mean? Court of Appeal Decides

Pharma & Life Sciences

Share this page: